Page last updated: 2024-09-05

cucurbitacin r and Colonic Neoplasms

cucurbitacin r has been researched along with Colonic Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Augenlicht, L; Escandell, JM; Kaler, P; Klampfer, L; Recio, MC; RĂ­os, JL; Sasazuki, T; Shirasawa, S1

Other Studies

1 other study(ies) available for cucurbitacin r and Colonic Neoplasms

ArticleYear
Activated kRas protects colon cancer cells from cucurbitacin-induced apoptosis: the role of p53 and p21.
    Biochemical pharmacology, 2008, Jul-15, Volume: 76, Issue:2

    Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Cyclin-Dependent Kinase Inhibitor p21; Humans; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); ras Proteins; Triterpenes; Tumor Suppressor Protein p53

2008